Development of an anti-Chlamydia vaccine for the koala. The koala is one of Australia's main icons and a major drawcard for tourists. However, it suffers from debilitating disease due to the bacterium Chlamydia, which can lead to severe conjunctivitis, eventual blindness in both sexes, and the females develop untreatable cysts and can become infertile. This project will develop a Chlamydia vaccine to be administered to healthy and diseased koalas in zoos, sanctuaries, koala care centres, relocat ....Development of an anti-Chlamydia vaccine for the koala. The koala is one of Australia's main icons and a major drawcard for tourists. However, it suffers from debilitating disease due to the bacterium Chlamydia, which can lead to severe conjunctivitis, eventual blindness in both sexes, and the females develop untreatable cysts and can become infertile. This project will develop a Chlamydia vaccine to be administered to healthy and diseased koalas in zoos, sanctuaries, koala care centres, relocation programs and eventually perhaps even wild populations. The vaccine findings may also be transferable to other animals and may also even assist the development of a human Chlamydia vaccine.Read moreRead less
Mechanisms of subversion of malarial immunity. This project will aim to understand how the Malaria parasite, which causes one of the world’s deadliest diseases, evades immunity. It will provide novel understanding of immunity against malaria and impact on current strategies to develop an efficacious vaccine or treatment for malaria.
Development of a safe and immunogenic anti-chlamydia vaccine for the koala. Many koala populations are under threat of extinction from chlamydial disease.The project will develop a chlamydial vaccine and conduct trials in several wild koala populations for safety and effectiveness.
Bacterial and host drivers of chlamydial blindness in koalas. Chlamydial infection of the eyes is a significant cause of disease and death in koalas, contributing to the ongoing decline of this native species. Little is known about what influences the outcome of these infections, challenging efforts to manage and control koala chlamydial blindness. This project aims to evaluate whether differences in the infecting Chlamydia pecorum strains or the koala immune response, are associated with the ou ....Bacterial and host drivers of chlamydial blindness in koalas. Chlamydial infection of the eyes is a significant cause of disease and death in koalas, contributing to the ongoing decline of this native species. Little is known about what influences the outcome of these infections, challenging efforts to manage and control koala chlamydial blindness. This project aims to evaluate whether differences in the infecting Chlamydia pecorum strains or the koala immune response, are associated with the outcome of chlamydial ocular infection. In addition to helping us to understand and prevent blindness in koalas, this project should significantly expand our knowledge of the koala immune system and generate an array of koala immunological assays, outcomes that may benefit all koala conservation efforts.Read moreRead less
Herpesvirus entry into mammalian hosts. Herpesviruses infect most mammals and cause much chronic disease. Our poor understanding of their host entry pathways limits infection control. The olfactory neuroepithelium has been identified as a key entry portal for both a murid herpesvirus and a human pathogen, Herpes simplex virus, suggesting that many herpesviruses use this route. Virions cross the olfactory mucus on neuronal cilia, then either infect neurons or transfer to glial cells for local spr ....Herpesvirus entry into mammalian hosts. Herpesviruses infect most mammals and cause much chronic disease. Our poor understanding of their host entry pathways limits infection control. The olfactory neuroepithelium has been identified as a key entry portal for both a murid herpesvirus and a human pathogen, Herpes simplex virus, suggesting that many herpesviruses use this route. Virions cross the olfactory mucus on neuronal cilia, then either infect neurons or transfer to glial cells for local spread. This project will identify key receptor interactions and map the extent of invasion. By advancing our basic understanding of these important viruses and their uptake at an abundantly exposed but little explored anatomical site, the project can establish a basis for vaccinating against chronic disease.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE220101221
Funder
Australian Research Council
Funding Amount
$453,614.00
Summary
Revealing bat antibody recognition mechanism against bat-borne viruses. Bats act as asymptomic reservoir hosts for numerous zoonotic viruses that are lethal in humans, indicating that the bat immune system can control these viruses. However, little is known about bat immunity including how bat antibodies recognise bat-borne viruses. This project aims to study bat anti-viral antibodies by utilising innovative protein engineering, cutting-edge cryo-EM technology and single-cell isolation and seque ....Revealing bat antibody recognition mechanism against bat-borne viruses. Bats act as asymptomic reservoir hosts for numerous zoonotic viruses that are lethal in humans, indicating that the bat immune system can control these viruses. However, little is known about bat immunity including how bat antibodies recognise bat-borne viruses. This project aims to study bat anti-viral antibodies by utilising innovative protein engineering, cutting-edge cryo-EM technology and single-cell isolation and sequencing. The project seeks to uncover bat-borne zoonotic virus glycoprotein architecture and reveal how bat antibodies function to inhibit viral infection. Expected outcomes will be new insight and tools to combat emerging and yet to emerge pathogens, enabling pandemic preparedness and increasing global biosecurity.
Read moreRead less
Developing a chlamydial vaccine for koalas. Developing a chlamydial vaccine for koalas . This project aims to produce an optimised, safe, field-tested, protective Chlamydia vaccine for koalas. In many regions of Australia, Chlamydia infection severely reduces female koala reproductive rates, threatening the species’ long term survival. This project builds on work developing a prototype vaccine for koala Chlamydia, and intends to produce a vaccine ready for potential registration and use by koala ....Developing a chlamydial vaccine for koalas. Developing a chlamydial vaccine for koalas . This project aims to produce an optimised, safe, field-tested, protective Chlamydia vaccine for koalas. In many regions of Australia, Chlamydia infection severely reduces female koala reproductive rates, threatening the species’ long term survival. This project builds on work developing a prototype vaccine for koala Chlamydia, and intends to produce a vaccine ready for potential registration and use by koala care centres, wildlife hospitals and government departments.Read moreRead less
Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in ....Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in the wild, leaving vaccination as the only realistic option. This is valuable for both wild and captive koalas; zoos report high animal losses due to KoRV-associated lymphoma. The main outcome will be a KoRV vaccine which can be combined with a Chlamydia vaccine which is being developed in parallel.Read moreRead less